
    
      Subjects will come to the clinic on 6 occasions: at screening, baseline, week 2, week 4, week
      8 (end of treatment/early termination) and week 10 (follow-up). The primary efficacy variable
      will be the IGA. Secondary efficacy variables will include IGA (Investigator's Global
      Assessment), SCORAD (Scoring Atopic Dermatitis) visual analog scale (VAS)), EASI, BSA (Body
      Surface Area), POEM (Patient Orientated Eczema Measure), DLQI (Dermatology Life Quality
      Index), and SCORAD.
    
  